Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 895-898

  Jacobs, Richard F ^a,h   Kaplan, Sheldon L ^b,c   Schutze, Gordon E ^a   Dajani, Adnan S ^d,e   Leggiadro, Robert J ^f   Rim, Choon Soo ^g   Puri, Surendra K ^g  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g SANOFI   (France)

^h Department of Pediatrics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; CHILD; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0029978260     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.895     Document Type: Article

References (33)

1. Allen, K. D. 1991. Penicillin-resistant pneumococci. J. Hosp. Infect. 17:3-13.
2. Appelbaum, P. C. 1987. World-wide development of antibiotic resistance in pneumococci. Eur. J. Clin. Microbiol. 6:367-377.
3. Appelbaum, P. C. 1992 Antimicrobial resistance in Streptococcus pneumomae: an overview. Clin. Infect. Dis. 15:77-83.
4. Asmar, B. I., M. C. Thirumoorthi, J. A. Buckley, D. M. Kobos, and A, S. Dajani. 1985. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis. Antimicrob. Agents Chemother. 28:138-140
5. Block, S., P. Wright, R. Finger, R. Leggiadro, M. Appleton, S. Kahn, and R. Hutchenson. 1994. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993, JAMA 271:421-422.
6. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
7. Caputo, G. M., P. C. Appelbaum, and H. H. Liu. 1993. Infections due to penicillin-resistant pneumococcr clinical, epidemiolagic, and microbiologic features. Arch. Intern. Med. 153:1301-1310.
8. Chesney, P. J. 1992. The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. Am. J. Dis. Child. 146:912-916
9. Craig, W. A. 1995 Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis 22:89-96.
10. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
11. Friedland, I. R., S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken, Jr. 1993. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pcdiatr. Infect. Dis. J. 12:196-200.
12. Haglund, L. A., G. R. Istre, D. A. Pickett, D. F. Welch, D. P. Fine, and the Pneumococcus Study Group. 1993. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J. Infect. Dis. 168:1532-1536.
13. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drugresistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
14. Jones, R. N., A. L. Barry, and R. R. Packer. 1984. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Diagn. Microbiol Infect. Dis. 2:37S-46S
15. Jorgenson, J. H., M. J. Ferraro, M. L. McElmeel, J. Spargo, J. M Swenson, and F. C. Tenover. 1994. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J. Clin. Microbiol. 32:159-163.
16. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
17. Leggiadro, R. J., F. F. Barrett, P. J. Chesney, Y. Davis, and F. C. Tenover. 1994 Invasive pneumococci with high level penicillin and cephalosporin resistance at a mid-south children's hospital. Pediatr. Infect. Dis J. 13: 320-322.
18. Macias, E. A., E. O. Mason, Jr., H. Y. Ocera, and M. T. LaRocco. 1994 Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J. Clin. Microbiol 32:430-432.
19. Mason, E. O, Jr., S. L. Kaplan, L. B. Lamberth, and J. Tillman. 1992. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use Antimicrob. Agents Chemother. 36:1703-1707.
20. Musher, D. M, 1992. Infections caused by Streptococcus pneumoniae. clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect Dis. 14:801-807.
21. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial susceptibility testing. M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
23. Parkinson, A. J., M. Davidson, M. A. Fitzgerald, L. R. Bulkow, and D. J. Parks. 1994. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J. Infect. Dis. 170:461-464.
24. Peretti, P., L. Sueri, M. Tosi, R. Ciammarughi, G. P. Cadeo, and B. Milanesi. 1984. Cefotaxime in the cerebrospinal fluid and serum in patients with purulent meningitis J. Antimicrob. Chemother. 14(Suppl. B):117-123.
25. Simberkoff, M. S. 1994. Drug-resistant pneumococcal infections in the United States JAMA 271:1875-1876.
26. Simpson, E. H., M. L. Cartter, and J. L. Hadler. 1994. Prevalence of penicillin-resistant Streptococcus pneumoniae - Connecticut, 1992-1993, JAMA 271:1572.
27. Sloas, M. M., F. F. Barrett, P. J. Chesney, B. K. English, B. C. Hill, F. C. Tenover, and R. J. Leggiadro. 1992. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meninaitis. Pcdiatr Infect. Dis. J. 11:662-666.
28. Tan, T. Q., E. O. Mason, Jr., and S. L. Kaplan. 1993. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics 92:761-767.
29. Tan, T. Q., G. E. Schutze, E. O. Mason, Jr., and S. L. Kaplan. 1994. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosponns. Antimicrob. Agents Chemother. 38:918-923.
30. Thompson, J. W., M. J. Lewno, and G. E. Schutze. 1994 Antibiotic-resistant pneumococcal disease at Arkansas Children's Hospital, 1990 to 1993. Pediatr. Infect. Dis. J. 13:408-409.
31. Todd, P. A., and R. N. Brogden. 1990. Cefotaxime an update of its pharmacology and therapeutic use. Drugs 40:608-651.
32. Trang, J. M., R. F. Jacobs, G. L. Kearns, A. L. Brown, T. G. Wells, F. L. Underwood, and R. B. Kluza. 1985. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimcrob. Agents Chemother. 28:791-795.
33. Welby, P. L., D. S. Keller, J. L. Cromien, P. Tebas, and G. A. Storch. 1994. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr. Infect. Dis. J. 13:281-287.